Abstract
Get full access to this article
View all access options for this article.
References
1.
Dua
V
,
Yadav
SP
,
Oberoi
J
,
Sachdeva
A.
Successful treatment of Trichosporon asahii infection with voriconazole after bone marrow transplant .
J Pediatr Hematol Oncol
. 2013 ;35 (3 ):237 –238 .
2.
Girmenia
C
,
Pagano
L
,
Martino
B.
Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with hematological malignancies: a retrospective multicenter study from Italy and review of the literature .
J Clin Microbiol
. 2005 ;43 (4 ):1818 –1828 .
3.
Miceli
M
,
Díaz
JA
,
Lee
SA.
Emerging opportunistic yeast infections .
Lancet Infect Dis
. 2011 ;11 (2 ):142 –151 .
4.
Maxfield
L
,
Matthews
J
,
Ambrosetti
D.
Trichosporon fungemia in a pediatric patient with acute lymphoblasic leukemia .
IDCases
. 2015 ;2 (4 ):106 –108 .
5.
Suzuki
K
,
Nakase
K
,
Kyo
T.
Fatal Trichosporon fungemia in patients with hematologic malignancies .
Eur J Haematol
. 2010 ;84 (5 ):441 –447 .
6.
Vasquez JA
Rhodotorula
Malassezia, trichosporon, and other yeast-like fungi . In:
Dismukes
WE
,
Pappas
PG
,
Sobel
JD
eds .
Clinical Mycology
. Oxford University Press ; 2003 :206 –217 .
7.
Falk
R
,
Wolf
DG
,
Shapiro
M
,
Polacheck
I.
Multidrug-resistant Trichosporon asahii isolates are susceptible to voriconazole .
J Clin Microbiol
. 2003 ;41 :911 .
8.
Paphitou
NI
,
Ostrosky-Zeichner
L
,
Paetznick
V
,
Rodriguez
JR
,
Chen
E
,
Rex
JH.
In vitro antifungal susceptibility of Trichosporon species .
Antimicrob Agents Chemother
. 2002 ;46 :1144 –1146 .